![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif)
anti-CD45 monoclonal antibody AHN-12 A high affinity IgG1 monoclonal antibody with potential immunotherapeutic activity. Anti-CD45 monoclonal antibody AHN-12 recognizes CD45, a transmembrane protein tyrosine phosphatase that is expressed on the surface of normal and malignant hematopoietic cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif)
Code name: | ![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif) | AHN-12 | | ![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif) |
Previous: | anti-CD30 monoclonal antibody XmAb2513, anti-CD33 monoclonal antibody-DM4 conjugate AVE9633, anti-CD37 single-chain polypeptide TRU-016, anti-CD38 monoclonal antibody, anti-CD45 monoclonal antibody | Next: | anti-CD70 monoclonal antibody MDX-1411, anti-CEA IgCD28TCR-transduced autologous T cells, anti-CEA/anti-DTPA-In (F6-734) bispecific antibody, anti-CS1 monoclonal antibody HuLuc63, anti-denatured collagen recombinant monoclonal antibody TRC093 |
|
![](https://webarchive.library.unt.edu/eot2008/20090511154708im_/http://www.cancer.gov/images/spacer.gif) |